Wordt geladen...
Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations
Tenofovir, currently marketed as the prodrug tenofovir disoproxil fumarate, is used clinically to treat patients with HIV/AIDS. The oral bioavailability of tenofovir is relatively low, limiting its clinical effectiveness. Encapsulation of tenofovir within modified long-circulating liposomes would de...
Bewaard in:
Gepubliceerd in: | Clin Pharmacol |
---|---|
Hoofdauteurs: | , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Dove Medical Press
2017
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5327912/ https://ncbi.nlm.nih.gov/pubmed/28260952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S119875 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|